403 related articles for article (PubMed ID: 29781408)
1. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder.
Cavanna AE
CNS Spectr; 2018 Jun; 23(3):213-218. PubMed ID: 29781408
[TBL] [Abstract][Full Text] [Related]
2. The neuropsychiatry of Gilles de la Tourette syndrome: The état de l'art.
Cavanna AE
Rev Neurol (Paris); 2018 Nov; 174(9):621-627. PubMed ID: 30098800
[TBL] [Abstract][Full Text] [Related]
3. The psychopathological spectrum of Gilles de la Tourette syndrome.
Cavanna AE; Rickards H
Neurosci Biobehav Rev; 2013 Jul; 37(6):1008-15. PubMed ID: 23131314
[TBL] [Abstract][Full Text] [Related]
4. The functional anatomy of Gilles de la Tourette syndrome.
Ganos C; Roessner V; Münchau A
Neurosci Biobehav Rev; 2013 Jul; 37(6):1050-62. PubMed ID: 23237884
[TBL] [Abstract][Full Text] [Related]
5. Tourette syndrome: the self under siege.
Leckman JF; Bloch MH; Scahill L; King RA
J Child Neurol; 2006 Aug; 21(8):642-9. PubMed ID: 16970864
[TBL] [Abstract][Full Text] [Related]
6. Tics and tourette syndrome.
Ganos C; Martino D
Neurol Clin; 2015 Feb; 33(1):115-36. PubMed ID: 25432726
[TBL] [Abstract][Full Text] [Related]
7. Premonitory Urges in Patients with Gilles de la Tourette Syndrome: An Italian Translation and a 7-Year Follow-up.
Gulisano M; Calì P; Palermo F; Robertson M; Rizzo R
J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):810-6. PubMed ID: 26288345
[TBL] [Abstract][Full Text] [Related]
8. [Tics and Gilles de la Tourette syndrome].
Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
[TBL] [Abstract][Full Text] [Related]
9. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
[TBL] [Abstract][Full Text] [Related]
10. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review.
Evans J; Seri S; Cavanna AE
Eur Child Adolesc Psychiatry; 2016 Sep; 25(9):939-48. PubMed ID: 26880181
[TBL] [Abstract][Full Text] [Related]
11. Tourette syndrome, co-morbidities and quality of life.
Eapen V; Snedden C; Črnčec R; Pick A; Sachdev P
Aust N Z J Psychiatry; 2016 Jan; 50(1):82-93. PubMed ID: 26169656
[TBL] [Abstract][Full Text] [Related]
12. Temporal relationship between premonitory urges and tics in Gilles de la Tourette syndrome.
Brandt VC; Beck C; Sajin V; Baaske MK; Bäumer T; Beste C; Anders S; Münchau A
Cortex; 2016 Apr; 77():24-37. PubMed ID: 26922503
[TBL] [Abstract][Full Text] [Related]
13. Parent and self-report health-related quality of life measures in young patients with Tourette syndrome.
Cavanna AE; Luoni C; Selvini C; Blangiardo R; Eddy CM; Silvestri PR; Cali' PV; Gagliardi E; Balottin U; Cardona F; Rizzo R; Termine C
J Child Neurol; 2013 Oct; 28(10):1305-8. PubMed ID: 22952315
[TBL] [Abstract][Full Text] [Related]
14. Life events and Tourette syndrome.
Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
[TBL] [Abstract][Full Text] [Related]
15. The behavioral spectrum of Gilles de la Tourette syndrome.
Cavanna AE; Servo S; Monaco F; Robertson MM
J Neuropsychiatry Clin Neurosci; 2009; 21(1):13-23. PubMed ID: 19359447
[TBL] [Abstract][Full Text] [Related]
16. [Gilles de la Tourette: The history of the man and his illness; a medical historical study].
Gilson F
Tijdschr Psychiatr; 2012; 54(7):427-36. PubMed ID: 22811054
[TBL] [Abstract][Full Text] [Related]
17. Disease-specific quality of life in young patients with tourette syndrome.
Cavanna AE; Luoni C; Selvini C; Blangiardo R; Eddy CM; Silvestri PR; Calì PV; Gagliardi E; Balottin U; Cardona F; Rizzo R; Termine C
Pediatr Neurol; 2013 Feb; 48(2):111-4. PubMed ID: 23337003
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Tourette Syndrome.
Gill CE; Kompoliti K
J Child Neurol; 2020 Feb; 35(2):166-174. PubMed ID: 31608744
[TBL] [Abstract][Full Text] [Related]
19. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
Szejko N; Saramak K; Lombroso A; Müller-Vahl K
Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
[TBL] [Abstract][Full Text] [Related]
20. [Gilles de la Tourette Syndrome: Symptoms, Causes and Therapy].
Jakubovski E; Müller-Vahl KR
Psychother Psychosom Med Psychol; 2017 Jun; 67(6):252-268. PubMed ID: 28722101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
